Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 5Breast Neoplasms 4Stomach Neoplasms 3Malnutrition 3Head and Neck Neoplasms 3Colonic Neoplasms 3Wilms Tumor 1Sarcoma 1Prostatic Neoplasms 1Prostatic Intraepithelial Neoplasia 1Peripheral Nervous System Diseases 1Peptic Ulcer 1Pancreatic Neoplasms 1Osteoporosis 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Myocardial Ischemia 1Mucositis 1Motor Activity 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hyperphagia 1Hepatitis C, Chronic 1Hematologic Neoplasms 1Heart Diseases 1

Interventions

Cisplatin 33Radiotherapy 23Cetuximab 18Paclitaxel 14Docetaxel 14pembrolizumab 13Carboplatin 12Fluorouracil 10Radiotherapy, Intensity-Modulated 8Nivolumab 8Drug Therapy 7Erlotinib Hydrochloride 6Panitumumab 5dacomitinib 4Radiation 4Methotrexate 4Esophagectomy 4130-nm albumin-bound paclitaxel 4durvalumab 3ON 01910 3Leucovorin 3Gemcitabine 3Chemoradiotherapy 3vandetanib 2palbociclib 2osimertinib 2nedaplatin 2fludarabine 2cabazitaxel 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Squamous Cell × Dietary Supplements × Clear all
NCT03476330 2026-04-20

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
48 enrolled 7 charts
Classical hematology

Carcinoma, Squamous Cell, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡